Cocaine-Specific Antibodies Blunt the Subjective Effects of Smoked Cocaine in Humans

Biological Psychiatry

Volumn 67, Issue 1, 2010, Pages 59-65

  Haney, Margaret ^a,b   Gunderson, Erik W ^d   Jiang, Huiping ^b   Collins, Eric D ^b,c   Foltin, Richard W ^a,b  

^a Columbia University ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Addiction; antibody; cocaine; dependence; immunotherapy; vaccination

Indexed keywords

COCAINE; COCAINE VACCINE; UNCLASSIFIED DRUG; VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; HUMAN; INTOXICATION; MALE; PRIORITY JOURNAL; SMOKING; TACHYCARDIA; VACCINATION; WITHDRAWAL SYNDROME;

ADULT; ANTIBODIES; BLOOD PRESSURE; COCAINE; COCAINE-RELATED DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; PAIN MEASUREMENT; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TIME FACTORS; VACCINATION;

EID: 71349084953     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.08.031     Document Type: Article

References (27)

1. Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: National Findings (2007), Office of Applied Studies, Rockville, MD National Survey on Drug Use and Health Series, H-32, Department of Health and Human Services Publication No. SMA 07-4293
2. Knapp W.P., Soares B., Farrell M., and Silva de Lima M. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database Syst Rev 3 (2007) CD003023
3. Karila L., Gorelick D., Weinstein A., Noble F., Benyamina A., Coscas S., et al. New treatments for cocaine dependence: A focused review. Int J Neuropsychopharmacol 11 (2008) 425-438
4. Haney M., and Spealman R. Controversies in translational research: Drug self-administration. Psychopharmacology (Berl) 199 (2008) 403-419
5. Carrera M.R., Ashley J.A., Parsons L.H., Wirsching P., Koob G.F., and Janda K.D. Suppression of psychoactive effects of cocaine by active immunization. Nature 378 (1995) 727-730
6. Balster R.L., and Schuster C.R. Fixed-interval schedule of cocaine reinforcement: Effect of dose and infusion duration. J Exp Anal Behav 20 (1973) 119-129
7. Abreu M.E., Bigelow G.E., Fleisher L., and Walsh S.L. Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacology (Berl) 154 (2001) 76-84
8. Orson F.M., Kinsey B.M., Singh R.A., Wu Y., Gardner T., and Kosten T.R. The future of vaccines in the management of addictive disorders. Curr Psychiatry Rep 9 (2007) 381-387
9. Fox B.S. Development of a therapeutic vaccine for the treatment of cocaine addiction. Drug Alcohol Depend 48 (1997) 153-158
10. Kantak K.M., Collins S.L., Bond J., and Fox B.S. Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010. Psychopharmacology (Berl) 153 (2001) 334-340
11. Johnson M.W., and Ettinger R.H. Active cocaine immunization attenuates the discriminative properties of cocaine. Exp Clin Psychopharmacol 8 (2001) 163-167
12. Carrera M.R., Ashley J.A., Zhou B., Wirsching P., Koob G.F., and Janda K.D. Cocaine vaccines: Antibody protection against relapse in a rat model. Proc Natl Acad Sci U S A 97 (2000) 6202-6206
13. Kantak K.M., Collins S.L., Lipman E.G., Bond J., Giovanoni K., and Fox B.S. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model. Psychopharmacology (Berl) 148 (2000) 251-262
14. Kosten T.R., Rosen M., Bond J., Settles M., Roberts J.S., Shields J., et al. Human therapeutic cocaine vaccine: Safety and immunogenicity. Vaccine 20 (2002) 1196-1204
15. Martell B.A., Mitchell E., Poling J., Gonsai K., and Kosten T.R. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry 58 (2005) 158-164
16. Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, Gardner T, Kosten TR (in press): Cocaine vaccine for the treatment of cocaine dependence in methadone maintained patients: A randomized double-blind placebo-controlled efficacy trial. Arch Gen Psychiatry 66:1116-1123.
17. Evans S.M., Haney M., and Foltin R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) 159 (2002) 397-406
18. Paula S., Tabet M.R., Farr C.D., Norman A.B., and Ball Jr. W.J. Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody. J Med Chem 47 (2004) 133-142
19. Foltin R.W., Fischman M.W., Nestadt G., Stromberger H., Cornell E.E., and Pearlson G.D. Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend 26 (1990) 145-154
20. Diggle P.J., Liang K.-Y., and Zeger S.L. Analysis of Longitudinal Data (1994), Oxford University Press, New York
21. Pentel P.R., and Keyler D.E. Vaccines to treat drug addiction. In: Levine M.M., Kaper J.B., Rappuoli R., Liu M.A., and Good M.F. (Eds). New Generation Vaccines. 3rd ed. (2004), Marcel Dekker, New York 1057-1066
22. Kosten T., and Owens S.M. Immunotherapy for the treatment of drug abuse. Pharmacol Ther 108 (2005) 76-85
23. Dickerson L.W., Rodak D.J., Kuhn F.E., Wahlstrom S.K., Tessel R.E., Visner M.S., et al. Cocaine-induced cardiovascular effects: Lack of evidence for a central nervous system site of action based on hemodynamic studies with cocaine methiodide. J Cardiovasc Pharmacol 33 (1999) 36-42
24. Koetzner L., Deng S., Sumpter T.L., Weisslitz M., Abner R.T., Landry D.W., and Woods J.H. Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys. J Pharmacol Exp Ther 296 (2001) 789-796
25. Foltin R.W., and Fischman M.W. Smoked and intravenous cocaine in humans: Acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257 (1991) 247-261
26. Haney M., and Kosten T.R. Therapeutic vaccines for substance dependence. Expert Rev Vaccines 3 (2004) 11-18
27. Byrnes-Blake K.A., Carroll F.I., Abraham P., and Owens S.M. Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats. Int Immunopharmacol 1 (2001) 329-338